Le Lézard
Classified in: Covid-19 virus
Subjects: Photo/Multimedia, IPO

CSOP Gold Futures Daily (-1X) Inverse Product (Stock Code: 7374.HK) to List on HKEX


CSOP Gold Futures Daily (-1X) Inverse Product (stock code:7374.HK) will be listed on Hong Kong Stock Exchange on 20 October, 2021. As the first inverse commodity product issued in Hong Kong, 7374.HK provides investment results closely corresponding to inverse (-1x) the daily performance of Solactive Gold 1-Day Rolling Futures Index (the "Index") by using a combination of a future-based replication strategy and a Swap-based synthetic replication strategy. 7374.HK attracted USD 12 million initial investment. The inception price per unit is around HKD 7.8 with trading lot of 100, and the entry investment is approximately HKD 780. Before 7374.HK, CSOP Gold Futures Daily (2x) Leveraged Product (stock code: 7299.HK) was launched on 5 June, 2020. Having accumulated USD 248.3 million in size and recorded HKD 30.37 million average daily trading volume as end of August 2021, 7299.HK is extensively invested by Hong Kong investors to express their positive view to gold price in the long run. 1Meanwhile, the listing of 7374.HK will help investors to handle the volatility and downtrend of gold price in the short run.

Gold has long been seen as a store of value and an important alternative to currency. The price of gold usually fluctuates around and is negatively correlated with US dollar over the long term. On 15 March, 2020, the Fed announced to carry out unlimited QE policy to increase the liquidity of U.S. banks. Its balance sheet has almost doubled from USD 4.31 trillion on 11 March 2020 to USD 8.33 trillion on 24 August 20212. Since then, along with the global panics over Covid-19, gold futures price has peaked due to the concerns over inflation in July 20203. Fed is likely to plan tapering the QE gradually and bringing monetary policy back to normal in view of an economic recovery. When the Fed's balance sheet is shrinking, it will pull out the liquidity from the market which could strengthen USD, thus inducing more uncertainties to gold prices in the short term. In addition to QE, major economies also lowered interest rates to stimulate the economy. At the outbreak of the pandemic, the Fed has trimmed the interest rate down from a previous target range of 1% ~1.25% to almost zero.4 Now, in response to a higher risk of inflation, the Fed is expected to wind down its pandemic-era stimulus program and raise the interest rate in near future. With a market consensus on a stronger USD, the gold prices may see a bigger swing in the following time.

Ms. Ding Chen, CEO of CSOP comments, "We are happy to see the warm market responses towards the commodity leveraged & inverse products. The success of 7299.HK gives us the confidence in launching the 7374.HK." Melody He, Managing Director and Head of Business Development, adds "From elevated tensions between the U.S. and China to the ongoing COVID-19 epidemics, the futures market has faced with more uncertainties than ever. We hope CSOP Gold Futures Daily (2x) Leveraged Product (7299.HK) and CSOP Gold Futures Daily (-1X) Inverse Product (7374.HK) will help investors weather the storm of increasing uncertainties."

About CSOP Asset Management Limited

CSOP Asset Management Limited ("CSOP") was founded in 2008 as the first offshore asset manager set up by a regulated asset management company in China. With a dedicated focus on China investing, CSOP manages public and private funds, as well as providing investment advisory services to Asian and global investors. In addition, CSOP is best known as an ETF leader in Asia. As of 31 August 2021, CSOP has more than USD 10.2 billion in assets under management.

IMPORTANT: Investments involve risks. Investment value may rise or fall. Past performance information presented is not indicative of future performance. Investors should refer to the Prospectus and the Product Key Facts Statement ("KFS") for further details, including product features and risk factors. Investors should not base on this material alone to make investment decisions

Product Risk Disclosure:

CSOP Gold Futures Daily (-1X) Inverse Product

CSOP Gold Futures Daily (-1x) Inverse Product (the "Product") is a sub-fund of CSOP Leveraged and Inverse Series II, an umbrella unit trust established under Hong Kong law. Units of the Product (the "Units") are traded in HKD on The Stock Exchange of Hong Kong Limited (the "SEHK") like stocks. It is a futures and swap based product with an objective to provide investment results that, before fees and expenses, closely correspond to the inverse (-1x) of the Daily performance of the Solactive Gold 1-Day Rolling Futures Index (the "Index"). It is denominated in USD. Creations and redemptions are in USD only.

Please note that the above listed investment risks are not exhaustive and investors should read the Prospectus and the Product Key Facts Statement in detail before making any investment decision.

CSOP Gold Futures Daily (2x) Leveraged Product

CSOP Gold Futures Daily (2x) Leveraged Product (the "Product") is a sub-fund of CSOP Leveraged and Inverse Series II, an umbrella unit trust established under Hong Kong law. Units of the Product (the "Units") are traded in HKD on The Stock Exchange of Hong Kong Limited (the "SEHK") like stocks. It is a futures-based product which invests directly in the Active Contracts of gold futures traded on the New York Commodity Exchange (COMEX) ("COMEX Gold Futures") to give the Product twice (2x) the Daily performance of the Solactive Gold 1-Day Rolling Futures Index (the "Index"). It is denominated in USD. Creations and redemptions are in USD only.

Please note that the above listed investment risks are not exhaustive and investors should read the Prospectus and the Product Key Facts Statement in detail before making any investment decision.

Index Provider Disclaimer

The Product is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Solactive Gold 1-Day Rolling Futures Index and/or the use of Solactive trade mark or the index price/prices of the Solactive Gold 1-Day Rolling Futures Index at any time or in any other respect. The Solactive Gold 1-Day Rolling Futures Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the Solactive Gold 1-Day Rolling Futures Index is calculated correctly. Irrespective of its obligations towards CSOP Asset Management Limited, Solactive AG has no obligation to point out errors in the Solactive Gold 1-Day Rolling Futures Index to third parties including but not limited to investors and/or financial intermediaries of the Product. Neither publication of the Solactive Gold 1-Day Rolling Futures Index by Solactive AG nor the licensing of the Solactive Gold 1-Day Rolling Futures Index or Solactive trade mark for the purpose of use in connection with the Product constitutes a recommendation by Solactive AG to invest capital in the Product nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in the Product. Remember, the information in the Prospectus does not constitute tax, legal or investment advice and is not intended as a recommendation for buying or selling securities. The information and opinions contained in the Prospectus have been obtained from public sources believed to be reliable, but no representation or warranty, express or implied, is made that such information is accurate or complete and it should not be relied upon as such. Solactive AG will not be responsible for the consequences of reliance upon any opinion or statement contained therein or for any omission.

This material has not been reviewed by the Securities and Futures Commission.

Issuer: CSOP Asset Management Limited

____________________________

1 Source: Bloomberg, CSOP Asset Management Limited, as of 31 August 2021
2 Source: Statista, as of 24 August 2021
3 Source: Bloomberg, as of 1 July 2020
4 Source: The Federal Reserve, as of 16 March 2020


These press releases may also interest you

at 09:35
Two large multi-state studies uncovered a highly effective way to improve antibiotic selection for patients hospitalized with pneumonia or urinary tract infections (UTI), enabling better antibiotic stewardship in hospitals, according to research...

at 09:25
The "The U.S. Telehealth Weight Loss Market" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering The report includes in-depth analyses of: the scope of telehealth usage in the U.S., telehealth user demographics, pros and...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...

at 08:45
Wolf Haldenstein Adler Freeman & Herz LLP  ("Wolf  Haldenstein") announces that a federal securities class action lawsuit has been filed in the United States District Court for the Southern  District of New York on behalf of investors who purchased...

at 08:00
Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals, is happy to announce that its wholly owned generic pharmaceutical subsidiary, Nora...

at 07:00
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...



News published on and distributed by: